...
机译:突变IDH1抑制剂可延缓生长并促进神经胶质瘤细胞的分化
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA,Department of Pharmacology, Weill-Cornett Graduate School of Biomedical Sciences, New York, NY 10021, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, LosAngeles, CA 90095, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, LosAngeles, CA 90095, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Department of Neurosurgery, Memonal Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Department of Pathology, Memonal Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA,Department of Neurosurgery, Memonal Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA,Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, LosAngeles, CA 90095, USA;
Agios Pharmaceuticals, Cambridge, MA 02139, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA,Department of Pharmacology, Weill-Cornett Graduate School of Biomedical Sciences, New York, NY 10021, USA,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;
机译:用靶向突变IDH1抑制剂AG-120治疗的急性髓样白血病和IDH1突变患者的临床分化和分化综合症的证据
机译:组织因子促进胶质瘤干细胞表型,并被突变体IDH1抑制
机译:通过在 IDH1 EM>中,通过促进Wnt /β-catenin信号传导来增强肿瘤侵袭性。
机译:胶质瘤细胞系中突变体和野生型IDH1相互作用网络的鉴定
机译:CDO在一组体细胞突变体中,在Ras诱导的形态转化,基因表达和锚定非依赖性生长的成肌分化和解离中的作用的结构功能分析。
机译:突变IDH1抑制剂可延缓生长并促进神经胶质瘤细胞的分化
机译:突变体IDH1的抑制剂延迟生长并促进胶质瘤细胞的分化